MedCity News April 3, 2024
In a letter, several stakeholders urged the Drug Enforcement Administration to release a revised proposed rule on the virtual prescribing of controlled substances. This comes as Covid-19 flexibilities that allow controlled substances to be prescribed via telehealth without an in-person exam are set to expire at the end of the year.
In an April 2 letter, a group of over 200 stakeholders urged the Drug Enforcement Administration (DEA) to release a revised proposed rule that would “permit and regulate the prescribing of controlled substances through telehealth.” The stakeholders include the Alliance for Connected Care, the American Telemedicine Association, ATA Action, the Consumer Technology Association, the Healthcare Information and Management Systems Society and the Partnership to Advance Virtual Care.
The DEA...
Today's Sponsors
Today's Sponsor